RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ)
$4.36 -0.05 (-1.1338%)
Analysed RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) News Sources
Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.
07-04-2026
yahoo.com
Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
08-04-2026
yahoo.com
Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases
16-04-2026
yahoo.com
Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026
20-04-2026
yahoo.com
Radiopharm Theranostics Reports Business Update
23-04-2026
yahoo.com
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on April 28, 2026
23-04-2026
yahoo.com
Radiopharm Theranostics ADR (RADX): Inside the Clinical Programs
28-04-2026
yahoo.com
Radiopharm Theranostics Highlights Phase 1 Pipeline, Eyes June RAD 101 Data at DB Conference
29-04-2026
marketbeat.com
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
29-04-2026
yahoo.com
RADX: Fiscal 3Q:26 Cash Flow Report
12-05-2026
yahoo.com
What is the current price of RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ)?
The current price of RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) is $4.36.
RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) absolute price change since previous trading day?
The absolute price change of RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) since the previous trading day is $-0.05.
RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) percentage price change since previous trading day?
The percentage price change of RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) since the previous trading day is -1.1338%.
What is the most recent average sentiment score for RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ)?
The most recent average sentiment score for RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ)?
The most recent sentiment for RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) is .
SEC-8K** Filing Available For RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.